Alec Machiels - 14 May 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
Issuer symbol
APLS
Transactions as of
14 May 2021
Net transactions value
-$106,800
Form type
4
Filing time
18 May 2021, 16:05:28 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $6,675 +2,500 +0.37% $2.67* 672,044 14 May 2021 Direct F1
transaction APLS Common Stock Sale $113,475 -2,500 -0.37% $45.39 669,544 14 May 2021 Direct F1
holding APLS Common Stock 1,950 14 May 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -2,500 -1.7% $0.000000 145,029 14 May 2021 Common Stock 2,500 $2.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise from 10B5-1 trading plan.
F2 Owned by spouse.
F3 This option was granted on December 5, 2013 and fully vested.